From the beginning, CES has contributed to the development of cryogenic pelletising and has gained extensive experience in this unique stabilisation process throughout the past 20 years. Based on this experience, CES Pharma Systems has developed a new line of pelletisers meeting today's standards in the pharmaceutical & biotech industries.
Instantaneous stability
Liquids, semi-liquids or even solutions with a higher viscosity are introduced in droplet form into liquid nitrogen. These droplets are flash frozen and possible degradation processes are effectively stopped so that the product quality is preserved. Due to the use of this cryogen and the consistent, pre-determined size of the droplets, our cryogenic pelletisers are capable to produce uniform, round-shaped pellets with a typical distribution of 2-5mm in a reliable and repeatable manner.
Unique process requires unique equipment
During the development of our pelletisers, we have always put product quality and ease of operation first. This has resulted in high quality, sanitary equipment where each aspect of the pelletising process can be flexibly controlled to ensure optimum compatibility of product, process and operator.
Flexible product
Besides its advantages as a stand-alone unit, cryogenic pelletisers can play a key role in improving the efficiency of stabilization processes of products, such as tablets, capsules, inhalable drugs,.... Since pelletising enables you to process these products as bulk, it offers the opportunity to simplify your production process by eliminating redundant intermediate packaging. Specifically for lyophilisation and freeze/thaw processes, the unique properties of cryo-pellets will improve the efficiency of those processes and reduce overall cycle times.
CES Pharma systems can offer a turn key pelletising solution for your product during its complete life cycle, from R&D up to full-scale production.
